PDL BioPharma, Inc. Accounts Payable

Accounts Payable of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Payable growth rates and interactive chart. Accounts payable (AP) represents a company's obligation to pay off a short-term debt to its creditors or suppliers. Accounts payable are amounts due to vendors or suppliers for goods or services received that have not yet been paid for. The sum of all outstanding amounts owed to vendors is shown as the accounts payable balance on the company's balance sheet. The increase or decrease in total AP from the prior period appears on the cash flow statement.


Highlights and Quick Summary

  • Accounts Payable for the quarter ending June 29, 2020 was $3.52 Million (a -32.61% decrease compared to previous quarter)
  • Year-over-year quarterly Accounts Payable decreased by -73.42%
  • Annual Accounts Payable for 2019 was $17.4 Million (a 32.17% increase from previous year)
  • Annual Accounts Payable for 2018 was $13.1 Million (a -33.58% decrease from previous year)
  • Annual Accounts Payable for 2017 was $19.8 Million (a 182.0% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Payable of PDL BioPharma, Inc.

Most recent Accounts Payableof PDLI including historical data for past 10 years.

Interactive Chart of Accounts Payable of PDL BioPharma, Inc.

PDL BioPharma, Inc. Accounts Payable for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $3.52 $5.23
2019 $2.68 $13.26 $14.81 $12.43 $17.37
2018 $13.14 $9.01 $11.21 $9.95 $13.14
2017 $19.79 $10.45 $10.39 $17.96 $19.79
2016 $7.02 $7.13 $1.07 $0.66 $7.02
2015 $0.39 $0.42 $0.7 $0.62 $0.39
2014 $0.32 $1.08 $0.34 $0.41 $0.32
2013 $0.29 $1.47 $0.12 $0.5 $0.29
2012 $1.07 $0.81 $0.16 $0.47 $1.07
2011 $0.53 $0.27 $0.12 $0.29 $0.53
2010 $2.54 $1.29 $0.18 $2.54

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.